ASHLEY BIGGS: Open Payments
NPI 1447425046 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,918 in 109 payments from 21 companies in 2025. Trend: 2023 $1,586 · 2024 $918 · 2025 $1,918
Food & beverage: $1,894Education: $24
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 20 | $312 |
| Regeneron Healthcare Solutions, Inc. | 11 | $223 |
| E.R. Squibb & Sons, L.L.C. | 12 | $215 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $150 |
| Galderma Laboratories, L.P. | 14 | $146 |
| Incyte Corporation | 5 | $98 |
| Janssen Biotech, Inc. | 4 | $93 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $68 |
| Lilly USA, LLC | 3 | $66 |
Products named: CIBINQO, Sotyktu, DUPIXENT, NEMLUVIO, OPZELURA, TREMFYA, ILUMYA, TALTZ.
Industry payments across OK — which companies pay providers there.
